Pharmacists are the medication experts on America’s health care team. The APhA Media Advisors and staff pharmacists can help the media make sense of pharmacist clinical services, over-the-counter products, prescription medications, vitamin and herbal supplements, as well as many other topics. These pharmacists are ready to help develop stories about medication use and how the pharmacist helps improve patient health and reduce health care costs.
Contact Chad Clinton in Communications at firstname.lastname@example.org or at 202-429-7558.
September 27, 2018
October is American Pharmacists Month
Monday marks first day of October and the start of American Pharmacists Month, a celebration in support of pharmacists around the country. The American Pharmacists Association (APhA) celebrates the accomplishments of pharmacists throughout the year but commemorates it during October by recognizing pharmacists’ contributions to health care and all they can do for their communities.
October 2, 2018
This American Pharmacists Month, tell the world that pharmacists…
Welcome to American Pharmacists Month 2018! On Tuesday, we enjoyed celebrating World Pharmacists Day. The event got tremendous attention on social media, so we send a shout out to all of you who took…0 comments
News View all news
States clash with cities over potential opioids settlement payouts
Lawyers for the nearly 2,000 cities and counties recently put forth a plan to jump-start negotiations toward a settlement in the massive federal opioid litigation is receiving pushback from states. A hearing on the proposal is scheduled for Tuesday in Cleveland before the federal judge who is overseeing the cases, Dan A. Polster.
APhA and other pharmacy organizations address pharmacist well-being
Enhancing Well-Being and Resilience Among the Pharmacist Workforce: A National Consensus Conference was held in Chicago from July 17-19, and was planned and implemented by APhA, the American Association of Colleges of Pharmacy, the Accreditation Council for Pharmacy Education, the National Association of Boards of Pharmacy, and the National
FDA approves first generics of pregabalin
FDA announced Monday that it has approved nine applications for the generic versions of pregabalin (Lyrica—Pfizer) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients aged 17 years a